PUBMED FOR HANDHELDS

Journal Abstract Search


727 related items for PubMed ID: 16863563

  • 1. Treatment of diarrhea-predominant irritable bowel syndrome with traditional Chinese herbal medicine: a randomized placebo-controlled trial.
    Leung WK, Wu JC, Liang SM, Chan LS, Chan FK, Xie H, Fung SS, Hui AJ, Wong VW, Che CT, Sung JJ.
    Am J Gastroenterol; 2006 Jul; 101(7):1574-80. PubMed ID: 16863563
    [Abstract] [Full Text] [Related]

  • 2. Symptomatic efficacy of beidellitic montmorillonite in irritable bowel syndrome: a randomized, controlled trial.
    Ducrotte P, Dapoigny M, Bonaz B, Siproudhis L.
    Aliment Pharmacol Ther; 2005 Feb 15; 21(4):435-44. PubMed ID: 15709995
    [Abstract] [Full Text] [Related]

  • 3. Efficacy of dioctahedral smectite in treating patients of diarrhea-predominant irritable bowel syndrome.
    Chang FY, Lu CL, Chen CY, Luo JC.
    J Gastroenterol Hepatol; 2007 Dec 15; 22(12):2266-72. PubMed ID: 17559369
    [Abstract] [Full Text] [Related]

  • 4. Efficacy and tolerability of alosetron for the treatment of irritable bowel syndrome in women and men: a meta-analysis of eight randomized, placebo-controlled, 12-week trials.
    Rahimi R, Nikfar S, Abdollahi M.
    Clin Ther; 2008 May 15; 30(5):884-901. PubMed ID: 18555935
    [Abstract] [Full Text] [Related]

  • 5. A randomized, double-blind, placebo-controlled trial of St John's wort for treating irritable bowel syndrome.
    Saito YA, Rey E, Almazar-Elder AE, Harmsen WS, Zinsmeister AR, Locke GR, Talley NJ.
    Am J Gastroenterol; 2010 Jan 15; 105(1):170-7. PubMed ID: 19809408
    [Abstract] [Full Text] [Related]

  • 6. A randomized, double-blind, placebo-controlled study to assess efficacy and safety of 0.5 mg and 1 mg alosetron in women with severe diarrhea-predominant IBS.
    Krause R, Ameen V, Gordon SH, West M, Heath AT, Perschy T, Carter EG.
    Am J Gastroenterol; 2007 Aug 15; 102(8):1709-19. PubMed ID: 17509028
    [Abstract] [Full Text] [Related]

  • 7. Tong-xie-ning, a Chinese herbal formula, in treatment of diarrhea-predominant irritable bowel syndrome: a prospective, randomized, double-blind, placebo-controlled trial.
    Wang G, Li TQ, Wang L, Xia Q, Chang J, Zhang Y, Wan MH, Guo J, Cheng Y, Huang X, Zhang RM.
    Chin Med J (Engl); 2006 Dec 20; 119(24):2114-9. PubMed ID: 17199964
    [No Abstract] [Full Text] [Related]

  • 8. Alosetron controls bowel urgency and provides global symptom improvement in women with diarrhea-predominant irritable bowel syndrome.
    Lembo T, Wright RA, Bagby B, Decker C, Gordon S, Jhingran P, Carter E, Lotronex Investigator Team.
    Am J Gastroenterol; 2001 Sep 20; 96(9):2662-70. PubMed ID: 11569692
    [Abstract] [Full Text] [Related]

  • 9. Tegaserod for female patients suffering from IBS with mixed bowel habits or constipation: a randomized controlled trial.
    Chey WD, Paré P, Viegas A, Ligozio G, Shetzline MA.
    Am J Gastroenterol; 2008 May 20; 103(5):1217-25. PubMed ID: 18477346
    [Abstract] [Full Text] [Related]

  • 10. A double blind randomized controlled trial of a probiotic combination in 100 patients with irritable bowel syndrome.
    Drouault-Holowacz S, Bieuvelet S, Burckel A, Cazaubiel M, Dray X, Marteau P.
    Gastroenterol Clin Biol; 2008 Feb 20; 32(2):147-52. PubMed ID: 18387426
    [Abstract] [Full Text] [Related]

  • 11. Efficacy of a Chinese Herbal Medicine in Providing Adequate Relief of Constipation-predominant Irritable Bowel Syndrome: A Randomized Controlled Trial.
    Bensoussan A, Kellow JE, Bourchier SJ, Fahey P, Shim L, Malcolm A, Boyce P.
    Clin Gastroenterol Hepatol; 2015 Nov 20; 13(11):1946-54.e1. PubMed ID: 26133902
    [Abstract] [Full Text] [Related]

  • 12. Randomized, double-blind, placebo-controlled trial of the 5-HT1A receptor antagonist AZD7371 tartrate monohydrate (robalzotan tartrate monohydrate) in patients with irritable bowel syndrome.
    Drossman DA, Danilewitz M, Naesdal J, Hwang C, Adler J, Silberg DG.
    Am J Gastroenterol; 2008 Oct 20; 103(10):2562-9. PubMed ID: 18775020
    [Abstract] [Full Text] [Related]

  • 13. Clinical trial: the effect of amitriptyline in patients with diarrhoea-predominant irritable bowel syndrome.
    Vahedi H, Merat S, Momtahen S, Kazzazi AS, Ghaffari N, Olfati G, Malekzadeh R.
    Aliment Pharmacol Ther; 2008 Apr 20; 27(8):678-84. PubMed ID: 18248658
    [Abstract] [Full Text] [Related]

  • 14. A dose-ranging, phase II study of the efficacy and safety of alosetron in men with diarrhea-predominant IBS.
    Chang L, Ameen VZ, Dukes GE, McSorley DJ, Carter EG, Mayer EA.
    Am J Gastroenterol; 2005 Jan 20; 100(1):115-23. PubMed ID: 15654790
    [Abstract] [Full Text] [Related]

  • 15. Effects of a proprietary Bacillus coagulans preparation on symptoms of diarrhea-predominant irritable bowel syndrome.
    Dolin BJ.
    Methods Find Exp Clin Pharmacol; 2009 Dec 20; 31(10):655-9. PubMed ID: 20140275
    [Abstract] [Full Text] [Related]

  • 16. Symptom management for irritable bowel syndrome: a pilot randomized controlled trial of acupuncture/moxibustion.
    Anastasi JK, McMahon DJ, Kim GH.
    Gastroenterol Nurs; 2009 Dec 20; 32(4):243-55. PubMed ID: 19696601
    [Abstract] [Full Text] [Related]

  • 17. Clinical trial: the efficacy of alverine citrate/simeticone combination on abdominal pain/discomfort in irritable bowel syndrome--a randomized, double-blind, placebo-controlled study.
    Wittmann T, Paradowski L, Ducrotté P, Bueno L, Andro Delestrain MC.
    Aliment Pharmacol Ther; 2010 Mar 20; 31(6):615-24. PubMed ID: 20003095
    [Abstract] [Full Text] [Related]

  • 18. A randomized, double-blind, placebo-controlled multicenter trial of saccharomyces boulardii in irritable bowel syndrome: effect on quality of life.
    Choi CH, Jo SY, Park HJ, Chang SK, Byeon JS, Myung SJ.
    J Clin Gastroenterol; 2011 Sep 20; 45(8):679-83. PubMed ID: 21301358
    [Abstract] [Full Text] [Related]

  • 19. Clinical trial: dextofisopam in the treatment of patients with diarrhoea-predominant or alternating irritable bowel syndrome.
    Leventer SM, Raudibaugh K, Frissora CL, Kassem N, Keogh JC, Phillips J, Mangel AW.
    Aliment Pharmacol Ther; 2008 Jan 15; 27(2):197-206. PubMed ID: 17973974
    [Abstract] [Full Text] [Related]

  • 20. Methotrexate versus traditional Chinese medicine in psoriasis: a randomized, placebo-controlled trial to determine efficacy, safety and quality of life.
    Ho SG, Yeung CK, Chan HH.
    Clin Exp Dermatol; 2010 Oct 15; 35(7):717-22. PubMed ID: 19925489
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 37.